Infant formula

Kabrita Brings the First and Only European and Goat Milk-Based Infant Formula to Meet All FDA Requirements to the U.S.

Retrieved on: 
Tuesday, January 9, 2024
Farm, Breast milk, Family, Milk, Sleep, FAAP, Infant formula, American Academy, Kabri, Israel, MSRP, Infant, FDA, Goat, Pediatrics (journal), Parent, Growth, Dairy

BOSTON, Jan. 9, 2024 /PRNewswire/ -- Kabrita, the leading global goat milk formula manufacturer, has introduced the first and only goat milk-based infant formula to meet all FDA requirements in the United States. This comes following years of clinical testing, proving Kabrita's infant formula is safe and that it can provide complete nutrition for a baby's growth in the first year. Kabrita can maintain consistent product production, giving parents peace of mind the infant formula is here for their baby's entire feeding journey.

Key Points: 
  • Produced with European Standards in the Netherlands, Kabrita's formula is backed by 75 years of trusted infant formula experience
    BOSTON, Jan. 9, 2024 /PRNewswire/ -- Kabrita , the leading global goat milk formula manufacturer, has introduced the first and only goat milk-based infant formula to meet all FDA requirements in the United States.
  • Kabrita can maintain consistent product production, giving parents peace of mind the infant formula is here for their baby's entire feeding journey.
  • With over 75 years of formula experience, Kabrita is the #1 goat milk formula worldwide, feeding 1.5 million babies daily.
  • Kabrita Goat Milk-Based Infant Formula is now available for purchase on Kabrita.com (two-pack for $89.99) and Amazon (suggested MSRP of $46.99).

Women-owned Startups Collaborate Toward a Scalable and Cost-Effective Future for Sustainable Biotechnology

Retrieved on: 
Thursday, October 26, 2023
Science, Genetic distance, Health, Research Triangle Park, Biotechnology, Carbon, Triangle Park (Quezon City), Milk, Protein, Infant formula, Growth, A-DNA, Alexandria Center of Arts, Plant, Tiamat, Breast milk, Prolactin, Hormone, Woman, Regenerative medicine, Lactation, Fine chemical, Dairy

By leveraging the potential of human mammary cells, BIOMILQ can bring more of the functional benefits of breast milk to more babies.

Key Points: 
  • By leveraging the potential of human mammary cells, BIOMILQ can bring more of the functional benefits of breast milk to more babies.
  • BIOMILQ and Tiamat Sciences are both headquartered in the Alexandria Center for AgTech – Research Triangle Park, a hub for emerging and global agtech companies.
  • In three months, Tiamat Sciences successfully produced Human Prolactin, a vital biomolecule for lactation, using an entirely animal-free production process.
  • BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside of the body.

a2 Platinum® Infant Formula Launches in U.S. - Made with Fresh a2 Milk®

Retrieved on: 
Wednesday, September 13, 2023
Vitamin E, DHA, Parent, Food safety, The a2 Milk Company, Infant formula, Science, Milk, Nutritional science, Formula, Amazon (company), Meijer, Growth, Infant, Choline, Caregiver, Wegman, Grocery store

BOULDER, Colo., Sept. 13, 2023 /PRNewswire/ -- The a2 Milk Company today announced that its highly regarded a2 Platinum® Premium Infant Formula will hit store shelves in the U.S. for the first time this month with initial distribution in nearly 250 Meijer stores (available now), and 50 Wegman's stores (available 9/18). It can also be purchased online at a2nutrition.com and is soon to be available on Amazon.com.

Key Points: 
  • a2 Platinum® has been sold internationally for more than a decade and is one of the top-10 Infant Formula brands globally with annual retail sales of over US $1 billion.
  • The product is made with fresh a2 Milk® sourced from carefully selected dairy farmers in New Zealand's pure and natural South Island.
  • Produced nearby at modern, state-of-the-art manufacturing facilities close to Christchurch, The a2 Milk Company prides itself on its food safety and quality standards with zero recalls.
  • With a2 Platinum®, the company is now bringing an infant formula made with a2 Milk® to U.S. parents and caregivers seeking alternatives for feeding newborns from 0-12 months.

FDA Authorizes Marketing of Kabrita's Goat Milk-Based Infant Formula in the US

Retrieved on: 
Tuesday, July 11, 2023
US Food Sovereignty Alliance, Hortensia Fussy, Parent, Colic, Infant formula, Science, Milk, Pesticide, Kabri, Israel, Randomized controlled trial, Growth, Infant, Lactose, FDA, Food, Safety, Farm, Breast milk, Dairy, Birth control

BOSTON, July 11, 2023 /PRNewswire/ -- Kabrita USA, a division of Ausnutria, a company with over 75 years of infant formula expertise and experience worldwide, announced today that its Kabrita Goat Milk-Based Infant Formula (0-12 months) meets all the US Food and Drug Administration's (FDA) nutrition and safety requirements and is authorized to market in the US. Kabrita Goat Milk-Based Infant Formula is expected to be available in the US later this year.

Key Points: 
  • Kabrita's Goat Milk-Based Infant Formula is the first European infant formula to meet the FDA's nutrition and safety requirements and will increase availability of infant formula across the country.
  • Kabrita Goat Milk-Based Infant Formula is expected to be available in the US later this year.
  • The FDA authorization of Kabrita Goat Milk-Based Infant Formula expands the Kabrita brand in the United States; Kabrita Goat Milk-Based Toddler Formula has been available in the US market since 2014.
  • To learn more about the science behind Kabrita Goat Milk-Based Infant Formula, please visit GetToKnowGoat.com .

Global Baby Food and Infant Formula Market to 2028: Burgeoning E-commerce Sector Fuels Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 6, 2023
Retail, Baby, Maternity, Food, Beverage, Consumer, Mineral, Parent, Nutrient, Infant, Vegetable, Infant formula, Milk, Vitamin, Protein, Water, Carbohydrate, Consciousness, Dietary supplement, Growth

The "Baby Food and Infant Formula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Baby Food and Infant Formula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global baby food and infant formula market size reached US$ 48.5 Billion in 2022.
  • As a result, they are shifting toward baby food and infant formula products that are rich in proteins, vitamins, minerals and carbohydrates.
  • The analyst provides an analysis of the key trends in each sub-segment of the global baby food and infant formula market report, along with forecasts at the global and regional level from 2023-2028.

SimpliFed Releases its Commitment Statement, Further Accentuating the Company’s Stance on a Mother’s Right to Choose How She Feeds Her Baby

Retrieved on: 
Thursday, March 30, 2023
Insurance, Partnership, Life, Commitment, Parent, Pediatrics (journal), Woman, American Academy, Research, Simplification, CDC, Surgeon, Patient, Infant, Infant formula, World Health Organization, Breast milk, Birth control

“This Commitment Statement underscores our mission to dissolve any stigma around the way one feeds their baby, and provide parents with evidence-based, patient-centric baby feeding support and all the tools they need to have a successful baby feeding experience.

Key Points: 
  • “This Commitment Statement underscores our mission to dissolve any stigma around the way one feeds their baby, and provide parents with evidence-based, patient-centric baby feeding support and all the tools they need to have a successful baby feeding experience.
  • That includes access to breast pumps and infant formula,” said Andrea Ippolito, CEO and founder of SimpliFed.
  • SimpliFed’s Commitment Statement accentuates the need for parental support for however one feeds their baby.
  • Parents are doing the best they can and SimpliFed provides them with the tools they need to nourish their baby and feel good about their choice.

FDA Gives Greenlight for Bobbie’s First of its Kind Tolerance Formula, Expanding Product Offering and Supporting More American Babies with High-Quality, Domestically Manufactured Organic Infant Formula

Retrieved on: 
Thursday, March 16, 2023
Parenting, FDA, Baby, Maternity, Fitness & Nutrition, Food, Beverage, Health, Consumer, Retail, Organic Food, Multimedia, Research, ARA, Medical research, Infant, Parent, Risk, Science and technology in Asia, Weight gain, Yale University, Life, Doctor of Pharmacy, Obesity, Protein, Science, DHA, Toddler, Perrigo, Lactose, Whey, AAP, Mother, Associate, Growth, Milk, Infant formula, Breast milk, Coronavirus Scientific Advisory Board, Organic, Cosmetics, Dairy, Dietary supplement, Toy, MD, RD, EU, Pediatrics, MPH, FAAP

Meet our new baby, Bobbie® Organic Gentle® -- due late Spring 2023. (Photo: Business Wire)

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230316005244/en/
    Meet our new baby, Bobbie® Organic Gentle® -- due late Spring 2023.
  • (Photo: Business Wire)
    Bobbie has never sacrificed their commitment to high-quality, organic ingredients—and are proud to expand this promise to parents seeking a tolerance formula with partially hydrolyzed protein.
  • Bobbie’s VP of Regulatory, Christina Berberich, PharmD, MPH, RD, and Mother worked with Perrigo to bring this ideal product into existence with Bobbie’s Organic Gentle Infant Formula.
  • “We established Bobbie Labs to evolve infant feeding while shaking the formula stigma within the research community and beyond.

Reckitt Recalls Two Batches of ProSobee 12.9 oz Simply Plant-Based Infant Formula Because of Possible Health Risk

Retrieved on: 
Monday, February 20, 2023
Women, Parenting, Other Retail, Baby, Maternity, Fitness & Nutrition, Supermarket, Food, Beverage, Consumer, Health, Retail, Cronobacter, World Health Organization, Safety, Infant, Parent, Cronobacter sakazakii, Bacteria, Universal Product Code, Multimedia, Infant formula, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Dietary supplement, Reckitt

Simply Plant-Based Infant Formula due to a possibility of cross-contamination with Cronobacter sakazakii.

Key Points: 
  • Simply Plant-Based Infant Formula due to a possibility of cross-contamination with Cronobacter sakazakii.
  • No other ProSobee Simply Plant-Based Infant Formula batches or other Reckitt products are impacted.
  • It is for this reason that we have the highest level of confidence in the safety and quality of every infant formula we make.
  • Consumers who purchased ProSobee Simply Plant-Based Infant Formula should check the bottom of the can to identify whether the batch number is affected.

Australian Company, Care A2 Plus Pty Ltd Partners with US Pharmaceutical, Gensco® Pharma

Retrieved on: 
Thursday, February 2, 2023
Caregiver, Science, Formula, Pharma, Breast milk, Criticism of the Food and Drug Administration, Woolworths Supermarkets, TerryWhite Chemmart, Infant, Medication, Nutrient, Food, Health, GMO, Parent, Absorption, Immune system, Lactoferrin, Partnership, FDA, Care, Infant formula, Supermarket, Kangaroo care, Dietary supplement, Pharmaceutical industry

DORAL, Fla., Feb. 2, 2023 /PRNewswire/ -- Amid a continuing supply chain crisis in the U.S. baby formula market, Australian health and wellness company, Care A2 Plus Pty Ltd ('Care'), and American Pharmaceutical Company, Gensco® Pharma, have announced a partnership to bring the already established Australian Infant formula into millions of American homes.

Key Points: 
  • DORAL, Fla., Feb. 2, 2023 /PRNewswire/ -- Amid a continuing supply chain crisis in the U.S. baby formula market, Australian health and wellness company, Care A2 Plus Pty Ltd ('Care'), and American Pharmaceutical Company, Gensco® Pharma, have announced a partnership to bring the already established Australian Infant formula into millions of American homes.
  • The Food and Drug Administration the U.S., certifying that the Australian-made Care A2+ Infant Formula meets the standards set by the FDA.
  • In early January 2023 the FDA extended the approval for Care A2+ to be sold in the US to October 2025.
  • Care A2+ is sold through major Australian retailers Woolworths Supermarkets and major Pharmaceutical outlets - Chemist Warehouse and Terry White Chemists.

Research Report on China's Infant Formula Import 2023-2032: Consumer Preference Remains with Imported Formula - ResearchAndMarkets.com

Retrieved on: 
Friday, January 13, 2023
Retail, Baby, Maternity, Food, Beverage, Consumer, Impact of the COVID-19 pandemic, Market, Birth rate, COVID-19, Research report, Competitive advantage, Infant formula, Dairy, Growth, China Energy Research Report, Infant, Clothing, Coal, Toy

The "Research Report on China's Infant Formula Import 2023-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Research Report on China's Infant Formula Import 2023-2032" report has been added to ResearchAndMarkets.com's offering.
  • In 2018, the average price of China's infant formula imports was US$14.70 per kg, and in 2021, the average price of China's infant formula imports was US$16.53 per kg, with an annual growth rate of about 4.00%.In 2022, from January to October, the average price of China's infant formula imports was US$16.77 per kg, an increase of 0.76% year-on-year.
  • In 2021, China imported 96,600 tons of infant formula from the Netherlands, accounting for 36.91% of total infant formula imports in that year.
  • Which Companies are the Major Players in China's Infant Formula Import Market and What are their Competitive Benchmarks?